553 related articles for article (PubMed ID: 18202014)
1. Small-molecule inhibition of 6-phosphofructo-2-kinase activity suppresses glycolytic flux and tumor growth.
Clem B; Telang S; Clem A; Yalcin A; Meier J; Simmons A; Rasku MA; Arumugam S; Dean WL; Eaton J; Lane A; Trent JO; Chesney J
Mol Cancer Ther; 2008 Jan; 7(1):110-20. PubMed ID: 18202014
[TBL] [Abstract][Full Text] [Related]
2. Small molecule inhibition of 6-phosphofructo-2-kinase suppresses t cell activation.
Telang S; Clem BF; Klarer AC; Clem AL; Trent JO; Bucala R; Chesney J
J Transl Med; 2012 May; 10():95. PubMed ID: 22591674
[TBL] [Abstract][Full Text] [Related]
3. Small molecule 3PO inhibits glycolysis but does not bind to 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 (PFKFB3).
Emini Veseli B; Perrotta P; Van Wielendaele P; Lambeir AM; Abdali A; Bellosta S; Monaco G; Bultynck G; Martinet W; De Meyer GRY
FEBS Lett; 2020 Sep; 594(18):3067-3075. PubMed ID: 32620030
[TBL] [Abstract][Full Text] [Related]
4. Targeting 6-phosphofructo-2-kinase (PFKFB3) as a therapeutic strategy against cancer.
Clem BF; O'Neal J; Tapolsky G; Clem AL; Imbert-Fernandez Y; Kerr DA; Klarer AC; Redman R; Miller DM; Trent JO; Telang S; Chesney J
Mol Cancer Ther; 2013 Aug; 12(8):1461-70. PubMed ID: 23674815
[TBL] [Abstract][Full Text] [Related]
5. PFKFB3 promotes endotoxemia-induced myocardial dysfunction through inflammatory signaling and apoptotic induction.
Tian W; Guo HS; Li CY; Cao W; Wang XY; Mo D; Hao XW; Feng YD; Sun Y; Lei F; Zhang HN; Zhao MG; Li XQ
Toxicol Appl Pharmacol; 2019 Apr; 368():26-36. PubMed ID: 30776389
[TBL] [Abstract][Full Text] [Related]
6. 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase and tumor cell glycolysis.
Chesney J
Curr Opin Clin Nutr Metab Care; 2006 Sep; 9(5):535-9. PubMed ID: 16912547
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of 6-phosphofructo-2-kinase (PFKFB3) suppresses glucose metabolism and the growth of HER2+ breast cancer.
O'Neal J; Clem A; Reynolds L; Dougherty S; Imbert-Fernandez Y; Telang S; Chesney J; Clem BF
Breast Cancer Res Treat; 2016 Nov; 160(1):29-40. PubMed ID: 27613609
[TBL] [Abstract][Full Text] [Related]
8. TGF-β1 targets Smad, p38 MAPK, and PI3K/Akt signaling pathways to induce PFKFB3 gene expression and glycolysis in glioblastoma cells.
Rodríguez-García A; Samsó P; Fontova P; Simon-Molas H; Manzano A; Castaño E; Rosa JL; Martinez-Outshoorn U; Ventura F; Navarro-Sabaté À; Bartrons R
FEBS J; 2017 Oct; 284(20):3437-3454. PubMed ID: 28834297
[TBL] [Abstract][Full Text] [Related]
9. Nuclear targeting of 6-phosphofructo-2-kinase (PFKFB3) increases proliferation via cyclin-dependent kinases.
Yalcin A; Clem BF; Simmons A; Lane A; Nelson K; Clem AL; Brock E; Siow D; Wattenberg B; Telang S; Chesney J
J Biol Chem; 2009 Sep; 284(36):24223-32. PubMed ID: 19473963
[TBL] [Abstract][Full Text] [Related]
10. Ras transformation requires metabolic control by 6-phosphofructo-2-kinase.
Telang S; Yalcin A; Clem AL; Bucala R; Lane AN; Eaton JW; Chesney J
Oncogene; 2006 Nov; 25(55):7225-34. PubMed ID: 16715124
[TBL] [Abstract][Full Text] [Related]
11. 3PO inhibits inflammatory NFκB and stress-activated kinase signaling in primary human endothelial cells independently of its target PFKFB3.
Wik JA; Lundbäck P; la Cour Poulsen L; Haraldsen G; Skålhegg BS; Hol J
PLoS One; 2020; 15(3):e0229395. PubMed ID: 32130250
[TBL] [Abstract][Full Text] [Related]
12. Role of Akt/PKB and PFKFB isoenzymes in the control of glycolysis, cell proliferation and protein synthesis in mitogen-stimulated thymocytes.
Houddane A; Bultot L; Novellasdemunt L; Johanns M; Gueuning MA; Vertommen D; Coulie PG; Bartrons R; Hue L; Rider MH
Cell Signal; 2017 Jun; 34():23-37. PubMed ID: 28235572
[TBL] [Abstract][Full Text] [Related]
13. 3PO as a Selective Inhibitor of 6-Phosphofructo-2-Kinase/Fructose-2,6-Biphosphatase 3 in A375 Human Melanoma Cells.
Kotowski K; Supplitt S; Wiczew D; Przystupski D; Bartosik W; Saczko J; Rossowska J; Drąg-Zalesińska M; Michel O; Kulbacka J
Anticancer Res; 2020 May; 40(5):2613-2625. PubMed ID: 32366406
[TBL] [Abstract][Full Text] [Related]
14. Expression of PFKFB3 and Ki67 in lung adenocarcinomas and targeting PFKFB3 as a therapeutic strategy.
Li X; Liu J; Qian L; Ke H; Yao C; Tian W; Liu Y; Zhang J
Mol Cell Biochem; 2018 Aug; 445(1-2):123-134. PubMed ID: 29327288
[TBL] [Abstract][Full Text] [Related]
15. Estradiol stimulates glucose metabolism via 6-phosphofructo-2-kinase (PFKFB3).
Imbert-Fernandez Y; Clem BF; O'Neal J; Kerr DA; Spaulding R; Lanceta L; Clem AL; Telang S; Chesney J
J Biol Chem; 2014 Mar; 289(13):9440-8. PubMed ID: 24515104
[TBL] [Abstract][Full Text] [Related]
16. Targeting the sugar metabolism of tumors with a first-in-class 6-phosphofructo-2-kinase (PFKFB4) inhibitor.
Chesney J; Clark J; Lanceta L; Trent JO; Telang S
Oncotarget; 2015 Jul; 6(20):18001-11. PubMed ID: 26221874
[TBL] [Abstract][Full Text] [Related]
17. Increased 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 activity in response to EGFR signaling contributes to non-small cell lung cancer cell survival.
Lypova N; Telang S; Chesney J; Imbert-Fernandez Y
J Biol Chem; 2019 Jul; 294(27):10530-10543. PubMed ID: 31126985
[TBL] [Abstract][Full Text] [Related]
18. Phosphorylation of the 6-phosphofructo-2-kinase/fructose 2,6-bisphosphatase/PFKFB3 family of glycolytic regulators in human cancer.
Bando H; Atsumi T; Nishio T; Niwa H; Mishima S; Shimizu C; Yoshioka N; Bucala R; Koike T
Clin Cancer Res; 2005 Aug; 11(16):5784-92. PubMed ID: 16115917
[TBL] [Abstract][Full Text] [Related]
19. Blockage of glycolysis by targeting PFKFB3 suppresses tumor growth and metastasis in head and neck squamous cell carcinoma.
Li HM; Yang JG; Liu ZJ; Wang WM; Yu ZL; Ren JG; Chen G; Zhang W; Jia J
J Exp Clin Cancer Res; 2017 Jan; 36(1):7. PubMed ID: 28061878
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of 6-phosphofructo-2-kinase (PFKFB3) induces autophagy as a survival mechanism.
Klarer AC; O'Neal J; Imbert-Fernandez Y; Clem A; Ellis SR; Clark J; Clem B; Chesney J; Telang S
Cancer Metab; 2014 Jan; 2(1):2. PubMed ID: 24451478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
